PYC pyc therapeutics limited

0.40%

$1.27

Well Peptidream was the company's chosen peer comparison and...

First 7 Last

Share
Profile

Follow
Akki

35,790 Posts.

555

17/11/15

22:16

Post #: 16418590
Share

Originally posted by onshow ↑

PYC doesnt have the easiest technology or IP to understand but once people wake up and work out just what PYC is about, what we are achieving and what we are trying to achieve i think we will see quite a steady and sustainable re-rate.

At the moment PYC is being valued as if we have something that others have already got, but people will soon wake up and work out that PYC has achieved something recently that others have tried to achieve for decades and we could just be the first company to achieve a ground breaking, life saving resolution to a world wide problem that has yet to be resolved but is what PYC is currently on the cusp of doing.

Put a value on the chance of delivering a cure for cancer directly into the cancer cells to destroy them.....

Personally i think its work for then the EV of $28 million the market is currently valuing PYC at.

If PYC was listed anywhere else eg. China, US, Europe where investors seem to have a better grasp on technologies like PYC's then id imagine we would be trading closer to the $100-$200m mark currently.

Time will tell but heading in the right direction in the right sector at the right time it seems.

Good luck all, bought a few more today also.

Expand

If PYC was listed anywhere else eg. China, US, Europe where investors seem to have a better grasp on technologies like PYC's then id imagine we would be trading closer to the $100-$200m mark currently.

Expand

Well Peptidream was the company's chosen peer comparison and they presently have a market cap of $1.7B - they have a lot of pharma deals not dissimilar to the ones PYC had in the past but they don't have any proprietary cancer candidates as far as I am aware - they're just the early stage discovery deals ?

PYC Price at posting: 1.8¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.27		Change 0.005(0.40%)		Mkt cap ! $740.7M

Open	High	Low	Value	Volume
$1.27	$1.29	$1.27	$406.0K	319.3K

Buyers (Bids)

No.	Vol.	Price($)
1	13987	$1.27

Sellers (Offers)

Price($)	Vol.	No.
$1.29	1380	1

View Market Depth

No.	Vol.	Price($)
1	13987	1.265
1	15000	1.260
1	12000	1.255
1	4000	1.225
1	20000	1.220

Price($)	Vol.	No.
1.290	25630	2
1.295	24500	1
1.300	59168	4
1.325	9001	1
1.330	20000	2

Last trade - 16.10pm 27/06/2025 (20 minute delay)

PYC (ASX) Chart

Well Peptidream was the company's chosen peer comparison and...

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Well Peptidream was the company's chosen peer comparison and...

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News